Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

High doses of finasteride cause cell growth and tumors in mice.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

Finasteride causes abnormal growth in male mice cells at high doses.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Spironolactone most effective for hirsutism, but has side effects.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Antiandrogen therapy helps treat genetic hair loss.

Alternative treatments show promise for hair growth beyond traditional methods.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Androgens play a key role in causing PCOS (Polycystic Ovary Syndrome).